We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-1.2%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$2.69B
AUM Growth
+$1.24B
Cap. Flow
+$1.33B
Cap. Flow %
49.46%
Top 10 Hldgs %
34.01%
Holding
2,874
New
141
Increased
1,804
Reduced
493
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 16.37%
2 Financials 11.09%
3 Healthcare 7.51%
4 Consumer Discretionary 6.8%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTBI icon
1601
Community Trust Bancorp
CTBI
$1.42B
$76.6K ﹤0.01%
1,521
-14
-0.9% -$743
JKHY icon
1602
Jack Henry & Associates
JKHY
$11.2B
$76.5K ﹤0.01%
419
+126
+43% +$22K
GSBC icon
1603
Great Southern Bancorp
GSBC
$879M
$76.2K ﹤0.01%
1,377
-510
-27% -$29.8K
RL icon
1604
Ralph Lauren
RL
$22.5B
$75.7K ﹤0.01%
343
+222
+183% +$55K
GABC icon
1605
German American Bancorp
GABC
$1.92B
$75.7K ﹤0.01%
2,018
-38
-2% -$1.5K
MTG icon
1606
MGIC Investment
MTG
$6.47B
$74.4K ﹤0.01%
3,003
+239
+9% +$5.79K
ITOT icon
1607
iShares Core S&P Total US Stock Market ETF
ITOT
$93.7B
$73.3K ﹤0.01%
601
-860
-59% -$111K
PGC icon
1608
Peapack-Gladstone Financial
PGC
$846M
$72.7K ﹤0.01%
2,560
+43
+2% +$1.35K
CRSR icon
1609
Corsair Gaming
CRSR
$1.15B
$72K ﹤0.01%
8,129
+46
+0.6% +$454
ESI icon
1610
Element Solutions
ESI
$8.89B
$71.7K ﹤0.01%
3,172
+1,270
+67% +$32.5K
ADPT icon
1611
Adaptive Biotechnologies
ADPT
$3.6B
$71.6K ﹤0.01%
9,635
+759
+9% +$5.83K
CALX icon
1612
Calix
CALX
$2.34B
$71.6K ﹤0.01%
2,020
-218
-10% -$8.09K
DNA icon
1613
Ginkgo Bioworks
DNA
$503M
$71.2K ﹤0.01%
+12,499
New +$127K
BWXT icon
1614
BWX Technologies
BWXT
$15.5B
$71.1K ﹤0.01%
721
+286
+66% +$31K
PHIN icon
1615
Phinia Inc
PHIN
$2.98B
$71K ﹤0.01%
1,673
+995
+147% +$47.7K
EPAM icon
1616
EPAM Systems
EPAM
$5.25B
$70.9K ﹤0.01%
420
+361
+612% +$79.6K
OPCH icon
1617
Option Care Health
OPCH
$3.53B
$70.1K ﹤0.01%
2,006
+271
+16% +$8.51K
DVAX
1618
DELISTED
Dynavax Technologies
DVAX
$70.1K ﹤0.01%
5,402
STAG icon
1619
STAG Industrial
STAG
$7.79B
$69.7K ﹤0.01%
1,929
+1,321
+217% +$46.1K
VEU icon
1620
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$69.4K ﹤0.01%
1,144
NBHC icon
1621
National Bank Holdings
NBHC
$1.9B
$69.3K ﹤0.01%
1,812
+1,766
+3,839% +$73.5K
AXIA
1622
AXIA Energia
AXIA
$23.2B
$69K ﹤0.01%
12,279
+6,901
+128% +$35.1K
PLYM
1623
DELISTED
Plymouth Industrial REIT
PLYM
$68.7K ﹤0.01%
4,215
+1,155
+38% +$19.5K
CNH
1624
CNH Industrial
CNH
$14.2B
$68.6K ﹤0.01%
5,590
+2,597
+87% +$32.6K
OKTA icon
1625
Okta
OKTA
$23.7B
$68.6K ﹤0.01%
652
+22
+3% +$2.15K

Similar funds

Quadrant Capital Group's Q1 2025 Portfolio in Review

As of Q1 2025, Quadrant Capital Group held 2,874 positions worth $2.69B, up 85% from $1.45B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group deployed $1.33B of net new capital in Q1 2025, opening 141 new positions and adding to 1,804 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 2 shares worth $1.6M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $9.59M trimmed.

  • Quadrant Capital Group's largest Q1 2025 buy was Berkshire Hathaway Class A: 2 shares worth $1.6M.
  • Quadrant Capital Group added most to Schwab Fundamental US Large Company Index ETF in Q1 2025, an estimated $104M increase.
  • Quadrant Capital Group's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $9.59M.
  • Quadrant Capital Group fully exited First Trust Value Line Dividend Fund in Q1 2025, selling an estimated $350K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $2.69B portfolio in Q1 2025.
  • Quadrant Capital Group opened 141 new positions and closed 131 in Q1 2025.
  • Quadrant Capital Group's portfolio value rose 85% quarter-over-quarter to $2.69B.

Based on Quadrant Capital Group's 13F filing for Q1 2025, filed 13 May 2025.